FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Shorla NDA Accepted for Breast/Ovarian Cancer

FDA accepts for review a Shorla Oncology NDA for SH-105 for treating breast and ovarian cancer.

latest-news-card-1
Human Drugs

Florida Drug Import Plan Non-Starter: Canada

Canadian officials say they will act to prevent Floridas importation of drugs from that country to cause a shortage in Canada.

latest-news-card-1
Human Drugs

ICH Viral Safety Evaluation Guidance

FDA publishes an ICH guidance on evaluating the viral safety of biotechnology products derived from human or animal cell lines.

latest-news-card-1
Human Drugs

No Clarity Yet on Ozempic Suicide Risk: FDA

FDA says it has not been able to establish a causal connection between suicidal ideation and drugs like Ozempic and Wegovy and is continuing to review...

latest-news-card-1

Stakeholders Take Shots at FDA SIUU Communication Guide

Four major stakeholder groups air their disagreement with an FDA revised draft guidance on firms communicating scientific information on unapproved us...

latest-news-card-1
Medical Devices

Zeta Surgical Cranial Navigation Device Cleared

FDA clears a Zeta Surgical 510(k) for its Zeta Cranial Navigation System.

latest-news-card-1
Human Drugs

Busse Hospital Recalls Tracheostomy Tray Kits

Busse Hospital Disposables recalls its Tracheostomy Care Tray, Dressing Change Tray, and Tracheostomy Care Set in response to Nurse Assists 11/2023 re...

latest-news-card-1
Federal Register

Draft Guide on ANDA Reconsideration

Federal Register notice: FDA makes available a draft guidance entitled Requests for Reconsideration at the Division Level Under GDUFA.

latest-news-card-1
Federal Register

Info Collection on E-Records/E-Signatures

Federal Register notice: FDA sends to OMB an information collection revision entitled Electronic Records; Electronic Signatures 21 CFR Part 11.

latest-news-card-1
Human Drugs

CGMP Violations at Woorilife & Health

FDA warns South Koreas Woorilife & Health about CGMP violations in its manufacturing of over-the-counter drugs.